Literature DB >> 27612441

Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration Equation.

Raul Fernandez-Prado1, Esmeralda Castillo-Rodriguez1, Fernando Javier Velez-Arribas2, Carolina Gracia-Iguacel3, Alberto Ortiz4.   

Abstract

Direct oral anticoagulants (DOACs) may require dose reduction or avoidance when glomerular filtration rate is low. However, glomerular filtration rate is not usually measured in routine clinical practice. Rather, equations that incorporate different variables use serum creatinine to estimate either creatinine clearance in mL/min or glomerular filtration rate in mL/min/1.73 m2. The Cockcroft-Gault equation estimates creatinine clearance and incorporates weight into the equation. By contrast, the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations estimate glomerular filtration rate and incorporate ethnicity but not weight. As a result, an individual patient may have very different renal function estimates, depending on the equation used. We now highlight these differences and discuss the impact on routine clinical care for anticoagulation to prevent embolization in atrial fibrillation. Pivotal DOAC clinical trials used creatinine clearance as a criterion for patient enrollment, and dose adjustment and Federal Drug Administration recommendations are based on creatinine clearance. However, clinical biochemistry laboratories provide CKD-EPI glomerular filtration rate estimations, resulting in discrepancies between clinical trial and routine use of the drugs.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Chronic kidney disease; Creatinine clearance; Glomerular filtration rate; Oral anticoagulation

Mesh:

Substances:

Year:  2016        PMID: 27612441     DOI: 10.1016/j.amjmed.2016.08.019

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective.

Authors:  Guo Yu; Guo-Fu Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-02       Impact factor: 2.441

2.  Gender-specific differences in hemodialysis patients: a multicenter longitudinal study from Serbia.

Authors:  Ljubica Djukanović; Višnja Ležaić; Nada Dimković; Jelena Marinković; Biserka Aksić Milićević; Svetlana Arsenijević; Aleksandra Arsenović; Biljana Ceković; Dejan Ćelić; Verica Djordjević; Miloš Djurin; Nenad Filipović; Selena Gajić; Branimir Haviža-Lilić; Miloš Jandrić; Nasta Jovanović; Violeta Knežević; Svetlana Krsmanović; Dragana Marković; Djoko Maksić; Jelena Maslovarić; Snežana Milanović; Branka Mitić; Ana Ostojić; Dobrila Petković; Dragana Pilipović; Miodrag Sokolović; Dragana Stanković; Marina Stojanović; Tatjana Stojšić Vuksanović; Biserka Tirmenštajn; Jadranka Uzelac; Nataša Vesić; Goran Vojinović; Vanja Vukša
Journal:  Int Urol Nephrol       Date:  2022-07-02       Impact factor: 2.370

Review 3.  GFR Measurement and Chemotherapy Dosing in Patients with Kidney Disease and Cancer.

Authors:  Blaithin A McMahon; Mitchell H Rosner
Journal:  Kidney360       Date:  2020-01-13

4.  Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function.

Authors:  Nita A Limdi; Timothy Mark Beasley; Jielin Sun; Norman Stockbridge; Michael Pacanowski; Jeffry Florian
Journal:  Clin Pharmacol Ther       Date:  2021-01-19       Impact factor: 6.903

Review 5.  Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations.

Authors:  Jens Lutz; Kerstin Jurk; Helmut Schinzel
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-06-12

6.  Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment.

Authors:  Nibal Chamoun; Hady Ghanem; Ahmad Hachem; Essa Hariri; Christelle Lteif; Hanine Mansour; Hani Dimassi; Richard Zalloum; Georges Ghanem
Journal:  BMC Pharmacol Toxicol       Date:  2019-05-07       Impact factor: 2.483

7.  The chaos of hypertension guidelines for chronic kidney disease patients.

Authors:  Esmeralda Castillo-Rodriguez; Beatriz Fernandez-Fernandez; Raquel Alegre-Bellassai; Mehmet Kanbay; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2019-09-28

8.  Predictive ability of creatinine clearance versus estimated glomerular filtration rate for outcomes in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry.

Authors:  Eitaro Kodani; Hiroshi Inoue; Hirotsugu Atarashi; Hirofumi Tomita; Ken Okumura; Takeshi Yamashita; Hideki Origasa
Journal:  Int J Cardiol Heart Vasc       Date:  2020-06-10

9.  Direct Measurement of Creatinine Clearance over a Short Interval in Intensive Care Settings.

Authors:  Lawrence Sc Law; Elaine Ag Lo; Siang F Yeoh
Journal:  Indian J Crit Care Med       Date:  2021-07

10.  Lesinurad: what the nephrologist should know.

Authors:  Maria Dolores Sanchez-Niño; Binbin Zheng-Lin; Lara Valiño-Rivas; Ana Belen Sanz; Adrian Mario Ramos; Jose Luño; Marian Goicoechea; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2017-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.